{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:55:34Z","timestamp":1790916934591,"version":"4.1.0"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Salivary microRNAs (miRNAs) have been investigated for oral cancer detection, but comparison with healthy volunteers does not establish performance among patients with oral mucosal lesions. This review maps evidence relevant to discrimination between oral squamous cell carcinoma or oral cancer (OSCC\/OC) and oral potentially malignant disorders (OPMDs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The evidence was organized as a scoping review with study-specific diagnostic descriptions. Clinical comparators, assay methods, thresholds, participant overlap and data provenance were charted. No estimates were pooled. Searches were executed on 8 September 2026 in PubMed (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009487), Web of Science Core Collection (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009362), Scopus (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009318) and the Cochrane Central Register of Controlled Trials (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200934), with 28 additional records identified through citation chasing and reference-list checking, for a total of 1,229 records. After removal of 412 duplicates and 15 records before screening, 802 titles and abstracts were screened; 54 full-text reports were sought, of which 3 could not be retrieved and 51 were assessed. Sixteen sources were included in the evidence map, comprising 13 primary studies and 3 contextual systematic reviews.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Three diagnostic reports contained five assay-level results for cancer vs. OPMD or oral lichen planus. A four-miRNA panel was reported to have 90% sensitivity and 82.7% specificity in 50 OC and 52 OPMD participants. Two individual miRNAs evaluated in the same 30 OSCC and 30 OPMD participants each had reported sensitivity of 70% and specificity of 60%. An additional oral lichen planus comparison had uncertain ROC analysis denominators and was retained without reconstructed counts. Repeated assays within a cohort were not considered independent studies. Small selected samples, data-derived thresholds, inconsistent reporting and limited independent validation restricted interpretation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Salivary miRNAs have shown study-specific discrimination between cancer and selected OPMD groups. Evidence does not establish a transportable accuracy estimate or clinical benefit for lesion triage. Prospective evaluation in consecutive lesion cohorts is needed before these assays can inform biopsy, referral or surveillance decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1949232","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:36:07Z","timestamp":1790915767000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Salivary microRNAs for oral cancer and oral potentially malignant disorder triage: a scoping review and evidence map"],"prefix":"10.3389","volume":"13","author":[{"given":"Jianbang","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Stomatology, Xiangtan Central Hospital","place":["Xiangtan, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Stomatology, Xiangtan Central Hospital","place":["Xiangtan, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanyue","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Central Hospital of Xiangtan (The Affiliated Hospital of Hunan University)","place":["Xiangtan, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinghua","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Central Hospital of Xiangtan (The Affiliated Hospital of Hunan University)","place":["Xiangtan, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Central Hospital of Xiangtan (The Affiliated Hospital of Hunan University)","place":["Xiangtan, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/s1470-2045(24)00458-3","article-title":"Global burden of oral cancer in 2022 attributable to smokeless tobacco and areca nut consumption: a population attributable fraction analysis","volume":"25","author":"Rumgay","year":"2024","journal-title":"Lancet Oncol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1600-0714.2007.00582.x","article-title":"Nomenclature and classification of potentially malignant disorders of the oral mucosa","volume":"36","author":"Warnakulasuriya","year":"2007","journal-title":"J Oral Pathol Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/odi.13704","article-title":"Oral potentially malignant disorders: a consensus report from an international seminar on nomenclature and classification, convened by the WHO collaborating centre for oral cancer","volume":"27","author":"Warnakulasuriya","year":"2021","journal-title":"Oral Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/hed.26006","article-title":"Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype","volume":"42","author":"Iocca","year":"2020","journal-title":"Head Neck"},{"key":"B6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1111\/jop.12726","article-title":"Prevalence of oral potentially malignant disorders: a systematic review and meta-analysis","volume":"47","author":"Mello","year":"2018","journal-title":"J Oral Pathol Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40496-014-0014-y","article-title":"Salivary biomarkers for detection of oral squamous cell carcinoma: current state and recent advances","volume":"1","author":"Yakob","year":"2014","journal-title":"Curr Oral Health Rep"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.3389\/fphys.2019.01476","article-title":"Salivary biomarkers for oral squamous cell carcinoma diagnosis and follow-up: current status and perspectives","volume":"10","author":"Cristaldi","year":"2019","journal-title":"Front Physiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1158\/1078-0432.ccr-09-0736","article-title":"Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection","volume":"15","author":"Park","year":"2009","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hed.21713","article-title":"Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma","volume":"34","author":"Liu","year":"2012","journal-title":"Head Neck"},{"key":"B11","doi-asserted-by":"publisher","first-page":"86S","DOI":"10.1177\/0022034514531018","article-title":"Genomewide study of salivary MicroRNAs for detection of oral cancer","volume":"93","author":"Momen-Heravi","year":"2014","journal-title":"J Dent Res"},{"key":"B12","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/odi.12340","article-title":"Salivary microRNAs in oral cancer","volume":"21","author":"Zahran","year":"2015","journal-title":"Oral Dis"},{"key":"B13","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s12105-023-01600-7","article-title":"Evaluation of diagnostic significance of salivary miRNA-184 and miRNA-21 in oral squamous cell carcinoma and oral potentially malignant disorders","volume":"17","author":"Garg","year":"2023","journal-title":"Head Neck Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41368-023-00273-w","article-title":"A novel saliva-based miRNA profile to diagnose and predict oral cancer","volume":"16","author":"Balakittnen","year":"2024","journal-title":"Int J Oral Sci"},{"key":"B15","doi-asserted-by":"publisher","first-page":"104465","DOI":"10.1016\/j.oraloncology.2019.104465","article-title":"Mirnas in liquid biopsy for oral squamous cell carcinoma diagnosis: systematic review and meta-analysis","volume":"99","author":"Rapado-Gonz\u00e1lez","year":"2019","journal-title":"Oral Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1082.e1","DOI":"10.1016\/j.joms.2020.12.043","article-title":"Blood and salivary microRNAs for diagnosis of oral squamous cell carcinoma: a systematic review and meta-analysis","volume":"79","author":"Liu","year":"2021","journal-title":"J Oral Maxillofac Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3390\/jpm11020101","article-title":"Salivary microRNA and oral squamous cell carcinoma: a systematic review","volume":"11","author":"Menini","year":"2021","journal-title":"J Pers Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105108","DOI":"10.1016\/j.archoralbio.2021.105108","article-title":"The role of differentially expressed salivary microRNA in oral squamous cell carcinoma. A systematic review","volume":"125","author":"Al Rawi","year":"2021","journal-title":"Arch Oral Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1186\/s12903-024-04986-0","article-title":"Identification of common salivary miRNA in oral lichen planus and oral squamous cell carcinoma: systematic review and meta-analysis","volume":"24","author":"Koopaie","year":"2024","journal-title":"BMC Oral Health"},{"key":"B20","doi-asserted-by":"publisher","first-page":"8128","DOI":"10.3390\/jcm14228128","article-title":"Salivary microRNAs as innovative biomarkers for diagnosis and prediction of the oral potentially malignant disorders transition towards oral cancer: a systematic review","volume":"14","author":"Osan","year":"2025","journal-title":"J Clin Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/m18-0850","article-title":"Prisma extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jama.2017.19163","article-title":"Preferred reporting items for a systematic review and meta-analysis of diagnostic test accuracy studies","volume":"319","author":"McInnes","year":"2018","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e012799","DOI":"10.1136\/bmjopen-2016-012799","article-title":"Stard 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration","volume":"6","author":"Cohen","year":"2016","journal-title":"BMJ Open"},{"key":"B24","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1177\/0962280215592269","article-title":"Performance of methods for meta-analysis of diagnostic test accuracy with few studies or sparse data","volume":"26","author":"Takwoingi","year":"2017","journal-title":"Stat Methods Med Res"},{"key":"B26","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3390\/cancers15010291","article-title":"Salivary miRNAs expression in potentially malignant disorders of the oral mucosa and oral squamous cell carcinoma: a pilot study on miR-21, miR-27b, and miR-181b","volume":"15","author":"Di Stasio","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.oraloncology.2015.11.017","article-title":"MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder","volume":"53","author":"Hung","year":"2016","journal-title":"Oral Oncol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jds.2021.09.020","article-title":"Exploiting salivary miR-375 as a clinical biomarker of oral potentially malignant disorder","volume":"17","author":"Tu","year":"2022","journal-title":"J Dent Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.oraloncology.2019.07.013","article-title":"Non-invasive screening of a microRNA-based dysregulation signature in oral cancer and oral potentially malignant disorders","volume":"96","author":"Yap","year":"2019","journal-title":"Oral Oncol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","article-title":"The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments","volume":"55","author":"Bustin","year":"2009","journal-title":"Clin Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1093\/bib\/bbv056","article-title":"Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR","volume":"17","author":"Marabita","year":"2016","journal-title":"Brief Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1373\/clinchem.2015.239459","article-title":"Data normalization strategies for microRNA quantification","volume":"61","author":"Schwarzenbach","year":"2015","journal-title":"Clin Chem"},{"key":"B33","doi-asserted-by":"publisher","first-page":"55","DOI":"10.7326\/m14-0697","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/m18-1376","article-title":"Probast: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989x06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.7150\/thno.45157","article-title":"Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma","volume":"11","author":"Romani","year":"2021","journal-title":"Theranostics"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1949232\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:36:21Z","timestamp":1790915781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1949232\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":36,"alternative-id":["10.3389\/fsurg.2026.1949232"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1949232","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1949232"}}